The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

Harvey Fierstein, the actor who memorably starred in Mrs. Doubtfire alongside Robin Williams and Sally Field, shared his ...

Zepbound, a popular weight loss drug, has become the first FDA-approved prescription medication to treat obstructive sleep ...

Lilly investors got the jitters, saw better opportunities elsewhere, or decided to hold onto their chips. In the third ...

What’s different is what the drug actually does for you which is I don’t feel like I’m dieting,” he explained. “I feel like a ...

"Zepbound is the first medication that significantly improves moderate-to-severe OSA and aids in long-term weight loss in adults with obesity." ...

FOX 8 News’ Wayne Dawson is sharing an update on his health after receiving a surprising diagnosis of oral cancer earlier ...

The FDA said studies have shown that by aiding weight loss, Zepbound improves sleep apnea symptoms in some patients.

The new approval means that insurance providers will likely cover the medication for people with sleep apnea and obesity.

According to Eli Lilly, the study showed that both medications offer significant weight loss benefits, but people treated with Zepbound lost more weight than those on Wegovy after 72 weeks of ...

global pharmaceutical giant Eli Lilly announced on Wednesday that its weight loss treatment, Zepbound (tirzepatide), outperformed Novo Nordisk’s Wegovy (semaglutide) in a recent clinical trial.

Eli Lilly and Company LLY announced earlier this week that its popular obesity drug, Zepbound (tirzepatide) outperformed rival Novo Nordisk’s NVO Wegovy (semaglutide) in a weight-loss head-to ...